The high cost of cancer treatment and adverse side effects of drug therapy remain major health issues worldwide. Medicinal plants (MP) can be used to promote new, safe, and effective anticancer medications. This study aimed to estimate the prevalence of MP use among cancer patients, investigate its association with sociodemographic and clinical factors, and provide available information about the species used.
Materials and methods
This was a cross-sectional study among 508 patients undergoing chemotherapy. Sociodemographic data and information on MPs used in cancer treatment were collected using face-to-face interviews and a questionnaire. Clinical data were obtained from the hospital database. Ethnobotanical indices, including relative citation frequency, informed consensus factor, and fidelity level, were determined for data analysis.
Results
43.2% of patients used MPs. Of these, 66.3% did not disclose information about MPs to their physicians, 54% experienced improvements, and 6% reported undesirable side effects associated with using MPs. There was a significant association of MPs use with disease duration (P = 0.037) and cancer type (P < 0.001). 27 plant species belonging to 17 families were identified, with Lamiaceae, Apiaceae, and Fabaceae being the most common. The most used species were Origanum compactum benth., Marrubium vulgare L., Trigonella foenum-graecum L., Aloysia citriodora, and Rosmarinus officinalis L.
Conclusion
This study showed a high prevalence of MPs use among patients undergoing chemotherapy. Although further studies are needed to investigate the efficacy and safety of commonly used species, our findings may be used to inform evidence-based guidelines, promote communication between cancer patients and healthcare providers, and develop new medicinal plants.
BrayFLaversanneMSungH, et al.Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin2024; 74(3): 229–63.
3.
SantucciCCarioliGBertuccioP, et al.Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev2020 Sep; 29(5): 367–81.
4.
Global Burden of Disease 2019 Cancer Collaboration, KocarnikJMComptonK, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022 Mar 1; 8(3): 420–44.
MillerKDNogueiraLDevasiaT, et al.Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin2022 Sep; 72(5): 409–36.
8.
HuangJSsentongoPSharmaR. Editorial: Cancer burden, prevention and treatment in developing countries. Front Public Health2022; 10: 1124473.
9.
Organization WH. Technical report: pricing of cancer medicines and its impacts: a comprehensive technical report for the World Health Assembly Resolution 70.12: operative paragraph 2.9 on pricing approaches and their impacts on availability and affordability of medicines for the prevention and treatment of cancer [Internet]. World Health Organization; 2018 [cited 2025 Jul 05]. Available from: https://iris.who.int/handle/10665/277190
10.
BourhiaMAbdelaziz ShahatAMohammed AlmarfadiO, et al.Ethnopharmacological Survey of Herbal Remedies Used for the Treatment of Cancer in the Greater Casablanca-Morocco. Evid Based Complement Alternat Med2019; 2019: 1613457.
11.
BouyahyaAAbriniJEt-TouysA, et al.Indigenous knowledge of the use of medicinal plants in the North-West of Morocco and their biological activities. European Journal of Integrative Medicine2017 Aug 1; 13: 9–25.
12.
BagcchiS. Herbal medicines safety concerns in patients with cancer. Lancet Oncol2016 Jan; 17(1): e10.
13.
ChebatASkalliSErrihaniH, et al.Étude de prévalence des effets indésirables liés à l’utilisation des plantes médicinales par les patients de l’Institut National d’Oncologie, Rabat. Phytothérapie2014; 12(1): 25–32.
14.
De AlmeidaEMFerreiraHJAlvesDRda SilvaWMB. Therapeutic potential of medicinal plants indicated by the Brazilian public health system in treating the collateral effects induced by chemotherapy, radiotherapy, and chemoradiotherapy: A systematic review. Complement Ther Med2020 Mar; 49: 102293.
15.
Asadi-SamaniMKootiWAslaniEShirzadH. A systematic review of Iran’s medicinal plants with Anticancer effects. Journal of Evidence-Based Complementary & Alternative Medicine2015; 21(2): 143–153. https://doi.org/10.1177/2156587215600873
16.
MbavengATKueteVEfferthT. Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets. Front Pharmacol2017; 8: 343.
17.
YinSYWeiWCJianFY, et al.Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med2013; 2013: 302426.
18.
MohamedAKarimaSNadiaO. The use of medicinal plants against cancer: An ethnobotanical study in the Beni Mellal-Khenifra Region in Morocco. European Journal of Integrative Medicine2022 Jun 1; 52: 102137.
19.
Ben-AryeESamuelsNGoldsteinLH, et al.Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals. Cancer2016 Feb 15; 122(4): 598–610.
AboufarasMSelmaouiKOuzennouN. Use of complementary traditional phytotherapy to manage cancer in Morocco: A decade-long review of ethnopharmacological studies. Journal of Herbal Medicine2021 Oct 1; 29: 100494.
22.
El OrfiNBoutayebSHaddou RahouB, et al.Use of Medicinal Plants by Cancer Patients Under Chemotherapy in the Northwest of Morocco (Rabat Area): Cross-Sectional Study. J Evid Based Integr Med2022; 27: 2515690X221128036.
WeckerleCSde BoerHJPuriRK, et al.Recommended standards for conducting and reporting ethnopharmacological field studies. Journal of Ethnopharmacology2018 Jan 10; 210: 125–32.
25.
TardíoJPardo de SantayanaM. Cultural Importance Indices: A Comparative Analysis Based on the Useful Wild Plants of Southern Cantabria (Northern Spain). Economic Botany2008 Jan 4; 62: 24–39.
26.
HeinrichMAnkliAFreiB, et al.Medicinal plants in Mexico: healers’ consensus and cultural importance. Soc Sci Med1998 Dec; 47(11): 1859–71.
27.
LeontiM. The relevance of quantitative ethnobotanical indices for ethnopharmacology and ethnobotany. J Ethnopharmacol2022 Apr 24; 288: 115008.
28.
SamouhYLemraniAMimouniH, et al.Ethnopharmacological Study of Herbal Medicines used to treat Cancer in Morocco. The Journal of Phytopharmacology2019 Jun 1; 8: 135–41.
29.
ToukabriISaidABHamdiA, et al.Patterns of complementary and alternative medicine use among Tunisian cancer patients. J Oncol Pharm Pract2021 Dec; 27(8): 1948–57.
30.
JohnsonSBParkHSGrossCP, et al.Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers. JAMA oncology2018; 4(10): 1375–1381.
31.
AmratiFEZBourhiaMSlighouaM, et al.Traditional medicinal knowledge of plants used for cancer treatment by communities of mountainous areas of Fez-Meknes-Morocco. Saudi Pharm J2021 Oct; 29(10): 1185–204.
32.
BazrafshaniMSKhandaniBKPardakhtyA, et al.The prevalence and predictors of using herbal medicines among Iranian cancer patients. Complement Ther Clin Pract2019 May; 35: 368–73.
33.
JamilaFMostafaE. Ethnobotanical survey of medicinal plants used by people in Oriental Morocco to manage various ailments. J Ethnopharmacol2014 May 28; 154(1): 76–87.
34.
BaumlJMChokshiSSchapiraMM, et al.Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey. Cancer2015 Jul 15; 121(14): 2431–8.
35.
JudsonPLAbdallahRXiongY, et al.Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center. Integr Cancer Ther2017 Mar; 16(1): 96–103.
36.
El HachlafiNBenkhairaNFeriounM, et al.Moroccan Medicinal Plants Used to Treat Cancer: Ethnomedicinal Study and Insights into Pharmacological Evidence. Evid Based Complement Alternat Med2022; 2022: 1645265.
37.
JerminiMDuboisJRodondiPY, et al.Complementary medicine uses during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre. Sci Rep2019 Mar 25; 9(1): 5078.
38.
KeeneMRHeslopIMSabesanSS, et al.Complementary and alternative medicine use in cancer: A systematic review. Complementary Therapies in Clinical Practice2019 May 1; 35: 33–47.
39.
AboufarasMSelmaouiKOuzennouN. Attitudes and beliefs towards the use of complementary and alternative medicine in cancer patients. European Journal of Integrative Medicine2023 Aug 1; 63: 102294.
40.
KadirMFBin SayeedMSMiaMMK. Ethnopharmacological survey of medicinal plants used by indigenous and tribal people in Rangamati, Bangladesh. Journal of Ethnopharmacology2012 Dec 18; 144(3): 627–37.
41.
FarooquiMHassaliMAShatarAKA, et al.Use of complementary and alternative medicines among Malaysian cancer patients: A descriptive study. J Tradit Complement Med2016 Oct; 6(4): 321–6.
42.
ErkuDAMekuriaABelachewSA. Complementary and Alternative Medicine use and Its Association with Quality of Life Among Cancer Patients Receiving Chemotherapy in Ethiopia: A Cross-Sectional Study. Value in Health2016 Nov 1; 19(7): A745.
43.
TarhanOAlacaciogluASomaliI, et al.Complementary-alternative medicine among cancer patients in the western region of Turkey. J BUON2009; 14(2): 265–9.
44.
RahouBKarimaERHanchiZ, et al.Self-reported Use of Complementary and Alternative Medicine among Moroccan Women with Breast Cancer. Cancer and Oncology Research2017 Feb 1; 5: 1–9.
45.
BazrafshaniMSPardakhtyAKalantari KhandaniB, et al.The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses. BMC Complement Med Ther2023 Feb 7; 23(1): 41.
46.
BoakyeDGüntherKNiedermaierT, et al.Associations between comorbidities and advanced stage diagnosis of lung, breast, colorectal, and prostate cancer: A systematic review and meta-analysis. Cancer Epidemiol2021 Dec; 75: 102054.
47.
TaïbiKAbderrahimLAFerhatK, et al.Ethnopharmacological study of natural products used for traditional cancer therapy in Algeria. Saudi Pharm J2020 Nov; 28(11): 1451–65.
48.
TahirMGebremichaelLBeyeneT, et al.Ethnobotanical study of medicinal plants in Adwa District, Central Zone of Tigray Regional State, Northern Ethiopia. J Ethnobiol Ethnomed2021 Dec 24; 17(1): 71.
49.
ChaachouayNBenkhnigueOFadliM, et al.Ethnobotanical and ethnopharmacological studies of medicinal and aromatic plants used in the treatment of metabolic diseases in the Moroccan Rif. Heliyon2019 Nov 1; 5(10): e02191.
50.
TrotterRLoganM. Informant Consensus: A New Approach for Identifying Potentially Effective Medicinal Plants. 2019. p. 91–112.
51.
HeinrichM. Ethnobotany and its role in drug development. Phytother Res2000 Nov; 14(7): 479–88.
52.
AungTNQuZKortschakRD, et al.Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. Int J Mol Sci2017 Mar 17; 18(3): 656.
53.
GaoQFengJLiuW, et al.Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Adv Drug Deliv Rev2022 Sep; 188: 114445.
54.
Ait AbderrahimLTaïbiKAit AbderrahimN, et al.Euphorbia honey and garlic: Biological activity and burn wound recovery. Burns2019 Nov 1; 45(7): 1695–706.
55.
AboufarasMSelmaouiKOuzennouN. Adverse effects of medicinal plants used by cancer patients in Beni Mellal and the communication of this use. E3S Web of Conferences2021 Jan 1; 319: 01107.
56.
BelloNWinit-WatjanaWBaqirW, et al.Disclosure and adverse effects of complementary and alternative medicine used by hospitalized patients in the North East of England. Pharm Pract (Granada)2012 Jul; 10(3): 125–35.
57.
AlsanadSMHowardRLWilliamsonEM. An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med2016 Oct 18; 16(1): 393.
58.
RodinoSButuM. Herbal Extracts—New Trends in Functional and Medicinal Beverages. 2019. p. 73–108.
59.
Ali-ShtayehMSJamousRMSalamehNMY, et al.Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns. J Ethnopharmacol2016 Jul 1; 187: 104–22.
60.
AboufarasMSelmaouiKOuzennouN. Efficacies and side effects of medicinal plants used by patients with cancer in Morocco: A retrospective treatment-outcome study. J Ethnopharmacol2023 Jan 30; 301: 115783.
61.
OkaiyetoKOguntibejuOO. African Herbal Medicines: Adverse Effects and Cytotoxic Potentials with Different Therapeutic Applications. Int J Environ Res Public Health2021 Jun 2; 18(11): 5988.
62.
BahallM. Prevalence, patterns, and perceived value of complementary and alternative medicine among HIV patients: a descriptive study. BMC Complement Altern Med2017 Aug 23; 17: 422.
63.
Alami MerrouniIElachouriM. Anticancer medicinal plants used by Moroccan people: Ethnobotanical, preclinical, phytochemical and clinical evidence. J Ethnopharmacol2021 Feb 10; 266: 113435.
64.
AberkaniKNafisAZgourdehZ, et al.Ethnobotanical study of medicinal plants used for cancer treatment at the province of Nador, Morocco. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas2024; 23(2): 326–35.
65.
KarousOBen Haj JilaniIGhrabi-GammarZ. Ethnobotanical Study on Plant Used by Semi-Nomad Descendants’ Community in Ouled Dabbeb—Southern Tunisia. Plants (Basel)2021 Mar 28; 10(4): 642.
66.
MiaraMDAit HammouMHadjadj-AoulS. Phytotherapy and taxonomy of spontaneous medicinal plants in the area of Tiaret (Algeria) [Phytothérapie et taxonomie des plantes médicinales spontanées dans la région de Tiaret (Algérie)]. Phytotherapie2013 Aug 1; 11: 206–18.
67.
EtsassalaNGERHusseinAANchuF. Potential Application of Some Lamiaceae Species in the Management of Diabetes. Plants (Basel)2021 Feb 1; 10(2): 279.
68.
AggarwalBBShishodiaS. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol2006 May 14; 71(10): 1397–421.
69.
PaunovicVKosicMDjordjevicS, et al.Marrubium vulgare ethanolic extract induces proliferation block, apoptosis, and cytoprotective autophagy in cancer cells in vitro. Cell Mol Biol (Noisy-le-grand)2016 Sep 30; 62(11): 108–14.
70.
KozyraMKorgaAOstrowskaM, et al.Cytotoxic activity of methanolic fractions of different Marrubium spp. against melanoma cells is independent of antioxidant activity and total phenolic content. FEBS Open Bio2020 Jan; 10(1): 86–95.
71.
Al-DabbaghBElhatyIAAl HroutA, et al.Antioxidant and anticancer activities of Trigonella foenum-graecum, Cassia acutifolia and Rhazya stricta. BMC Complement Altern Med2018 Aug 22; 18(1): 240.
72.
El BairiKOuzirMAgnieszkaN, et al.Anticancer potential of Trigonella foenum graecum: Cellular and molecular targets. Biomed Pharmacother2017 Jun; 90: 479–91.
73.
HurrellJA. Aloysia citriodora Palau. In: AlbuquerqueUPatilUMáthéÁ (eds) Medicinal and Aromatic Plants of South America. Medicinal and Aromatic Plants of the World. 5. Dordrecht: Springer, 2018.
74.
OukerrouMATilaouiMMouseHA, et al.Chemical Composition and Cytotoxic and Antibacterial Activities of the Essential Oil of Aloysia citriodora Palau Grown in Morocco. Adv Pharmacol Sci2017; 2017: 7801924.
75.
de OliveiraJRCamargoSEAde OliveiraLD. Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent. J Biomed Sci2019 Jan 9; 26(1): 5.
76.
KontogianniVGTomicGNikolicI, et al.Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity. Food Chem2013 Jan 1; 136(1): 120–9.
77.
WahidCMeddahBMohammedH. Antiproliferative activity of Origanum compactum extract on lung cancer and hepatoma cells. 2015 Aug.
78.
BouyahyaABakriYEt-TouysA, et al.In vitro antiproliferative activity of selected medicinal plants from the North-West of Morocco on several cancer cell lines. European Journal of Integrative Medicine2018 Feb 1; 18: 23–9.
79.
LeeKWChingSMHooFKRamachandranVSwamyMK.Traditional Medicinal Plants and Their Therapeutic Potential Against Major Cancer Types. In: AkhtarMSSwamyMK, eds. Anticancer Plants: Natural Products and Biotechnological Implements [Internet]. Singapore: Springer Singapore; 2018 [cited 2025 Feb 20]. p. 383–410. Available from: http://link.springer.com/10.1007/978-981-10-8064-7_16
80.
PoonthananiwatkulBHowardRLWilliamsonEMLimRHM. Cancer patients taking herbal medicines: A review of clinical purposes, associated factors, and perceptions of benefit or harm. Journal of Ethnopharmacology2015 Dec 4; 175: 58–66.
81.
National Center for Complementary and Integrative Health. [Internet]. [cited 2025 Feb 18]. NCCIH. Available from: https://nccih.nih.gov/health/whatiscam
82.
BramiCBouchéOKarpJ-CCuréH. La cancérologie intégrative ou l’utilisation des thérapies complémentaires. À propos d’un modèle américain. Bull Cancer2014; 101: 531–2.
83.
LodhiSVadnereGSharmaV, et al.Marrubium vulgare L.: A review on phytochemical and pharmacological aspects. J Intercult Ethnopharmacol2017; 6(4): 429.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
